• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟疾抗原 Pfs48/45 上有效阻断传播表位 I 的结构描绘。

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.

机构信息

Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, M5G 0A4, ON, Canada.

Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, 6500 HB, Netherlands.

出版信息

Nat Commun. 2018 Oct 26;9(1):4458. doi: 10.1038/s41467-018-06742-9.

DOI:10.1038/s41467-018-06742-9
PMID:30367064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6203815/
Abstract

Interventions that can block the transmission of malaria-causing Plasmodium falciparum (Pf) between the human host and Anopheles vector have the potential to reduce the incidence of malaria. Pfs48/45 is a gametocyte surface protein critical for parasite development and transmission, and its targeting by monoclonal antibody (mAb) 85RF45.1 leads to the potent reduction of parasite transmission. Here, we reveal how the Pfs48/45 6C domain adopts a (SAG1)-related-sequence (SRS) fold. We structurally delineate potent epitope I and show how mAb 85RF45.1 recognizes an electronegative surface with nanomolar affinity. Analysis of Pfs48/45 sequences reveals that polymorphisms are rare for residues involved at the binding interface. Humanization of rat-derived mAb 85RF45.1 conserved the mode of recognition and activity of the parental antibody, while also improving its thermostability. Our work has implications for the development of transmission-blocking interventions, both through improving vaccine designs and the testing of passive delivery of mAbs in humans.

摘要

干预措施可以阻断疟原虫(Pf)在人类宿主和疟蚊媒介之间的传播,从而有潜力降低疟疾的发病率。Pfs48/45 是一种配子体表面蛋白,对寄生虫的发育和传播至关重要,其单克隆抗体(mAb)85RF45.1 的靶向作用导致寄生虫传播的有效减少。在这里,我们揭示了 Pfs48/45 6C 结构域如何采用(SAG1)相关序列(SRS)折叠。我们对有效表位 I 进行了结构划分,并展示了 mAb 85RF45.1 如何识别具有纳摩尔亲和力的带负电荷表面。对 Pfs48/45 序列的分析表明,在结合界面上涉及的残基的多态性很少。鼠源性 mAb 85RF45.1 的人源化保留了亲本抗体的识别模式和活性,同时还提高了其热稳定性。我们的工作对开发传播阻断干预措施具有重要意义,既可以通过改进疫苗设计,也可以通过测试在人类中被动输送 mAbs。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/7c376533e1f0/41467_2018_6742_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/d37942fc9621/41467_2018_6742_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/f5695c5785ed/41467_2018_6742_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/40fc53888683/41467_2018_6742_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/ceab8322e522/41467_2018_6742_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/7c376533e1f0/41467_2018_6742_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/d37942fc9621/41467_2018_6742_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/f5695c5785ed/41467_2018_6742_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/40fc53888683/41467_2018_6742_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/ceab8322e522/41467_2018_6742_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/6203815/7c376533e1f0/41467_2018_6742_Fig5_HTML.jpg

相似文献

1
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.疟疾抗原 Pfs48/45 上有效阻断传播表位 I 的结构描绘。
Nat Commun. 2018 Oct 26;9(1):4458. doi: 10.1038/s41467-018-06742-9.
2
Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.通过SpyTag/SpyCatcher介导的病毒样展示提高基于恶性疟原虫48/45的疫苗抗原的疟疾传播阻断活性。
Vaccine. 2017 Jun 27;35(30):3726-3732. doi: 10.1016/j.vaccine.2017.05.054. Epub 2017 May 31.
3
A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies.恶性疟原虫48/45单表位R0.6C亚基蛋白可引发高水平的传播阻断抗体。
Vaccine. 2015 Apr 15;33(16):1981-6. doi: 10.1016/j.vaccine.2015.02.040. Epub 2015 Feb 26.
4
Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.与嗜热四膜虫颗粒晶格蛋白1融合可使疟原虫有性阶段抗原在大肠杆菌中具有溶解性。
Protein Expr Purif. 2019 Jan;153:7-17. doi: 10.1016/j.pep.2018.08.001. Epub 2018 Aug 3.
5
Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.疟疾传播阻断疫苗靶向 Pfs230 和 Pfs230-Pfs48/45 蛋白的结构与功能。
Commun Biol. 2020 Jul 24;3(1):395. doi: 10.1038/s42003-020-01123-9.
6
Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate.恶性疟原虫传播阻断疫苗候选抗原Pfs48/45变异表位的地理分布
Mol Biochem Parasitol. 1996 Oct 30;81(2):253-7. doi: 10.1016/0166-6851(96)02718-1.
7
Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.GMZ2'.10C的表达、纯化及特性分析,GMZ2'.10C是一种针对导致疟疾的恶性疟原虫无性和有性生命周期的复杂二硫键连接融合蛋白候选疫苗。
Pharm Res. 2017 Sep;34(9):1970-1983. doi: 10.1007/s11095-017-2208-1. Epub 2017 Jun 23.
8
Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.疟疾疫苗候选抗原MSP2保守C端结构域中关键表位的结构与鉴定
J Mol Biol. 2017 Mar 24;429(6):836-846. doi: 10.1016/j.jmb.2017.02.003. Epub 2017 Feb 8.
9
Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies.自然接触寄生虫可诱导人体产生保护性抗疟抗体。
Immunity. 2017 Dec 19;47(6):1197-1209.e10. doi: 10.1016/j.immuni.2017.11.007. Epub 2017 Nov 29.
10
s230 and s48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against .s230 和 s48/45 融合蛋白引发针对. 的强烈传播阻断抗体反应。
Front Immunol. 2019 Jun 5;10:1256. doi: 10.3389/fimmu.2019.01256. eCollection 2019.

引用本文的文献

1
A combined designed CSP and Pfs48/45 infection and transmission blocking vaccine for malaria.一种用于疟疾的联合设计的CSP和Pfs48/45感染及传播阻断疫苗。
NPJ Vaccines. 2025 Sep 2;10(1):208. doi: 10.1038/s41541-025-01262-2.
2
Structural elucidation of full-length Pfs48/45 in complex with potent monoclonal antibodies isolated from a naturally exposed individual.与从自然暴露个体中分离出的强效单克隆抗体复合的全长Pfs48/45的结构解析
Nat Struct Mol Biol. 2025 May 22. doi: 10.1038/s41594-025-01532-6.
3
Nanobody-mediated targeting of Plasmodium falciparum PfPIMMS43 can block malaria transmission in mosquitoes.

本文引用的文献

1
Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.解析恶性疟原虫传播阻断性免疫的免疫特征。
Nat Commun. 2018 Feb 8;9(1):558. doi: 10.1038/s41467-017-02646-2.
2
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.抗体抑制疟疾传播阻断疫苗抗原 Pfs25 的多个作用点的分子定义。
Nat Commun. 2017 Nov 16;8(1):1568. doi: 10.1038/s41467-017-01924-3.
3
Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts.
纳米抗体介导的恶性疟原虫PfPIMMS43靶向作用可阻断疟疾在蚊子体内的传播。
Commun Biol. 2025 Apr 30;8(1):683. doi: 10.1038/s42003-025-08033-8.
4
Functionality of Toxoplasma gondii antibodies in a population of Beninese pregnant women exposed to malaria.在接触疟疾的贝宁孕妇群体中弓形虫抗体的功能。
Sci Rep. 2025 Mar 18;15(1):9303. doi: 10.1038/s41598-025-91803-5.
5
Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies.内源性Pfs230与Pfs48/45和强效疟疾传播阻断抗体形成的复合物的结构
bioRxiv. 2025 Feb 15:2025.02.14.638310. doi: 10.1101/2025.02.14.638310.
6
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.针对疟疾传播的瓶颈:抗体-表位描述指导下一代生物医学干预措施的设计。
Immunol Rev. 2025 Mar;330(1):e70001. doi: 10.1111/imr.70001.
7
Target-agnostic identification of human antibodies to sexual forms reveals cross-stage recognition of glutamate-rich repeats.对性形态的人源抗体进行与靶点无关的鉴定,揭示了对富含谷氨酸重复序列的跨阶段识别。
Elife. 2025 Jan 16;13:RP97865. doi: 10.7554/eLife.97865.
8
Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum.多样性和选择分析将阻断传播的抗原确定为恶性疟原虫的最佳疫苗候选物。
EBioMedicine. 2024 Aug;106:105227. doi: 10.1016/j.ebiom.2024.105227. Epub 2024 Jul 16.
9
Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in .多样性和选择分析确定传播阻断抗原是……中最佳的疫苗候选物。
medRxiv. 2024 May 12:2024.05.11.24307175. doi: 10.1101/2024.05.11.24307175.
10
Vaccines and monoclonal antibodies: new tools for malaria control.疫苗和单克隆抗体:疟疾控制的新工具。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0007123. doi: 10.1128/cmr.00071-23. Epub 2024 Apr 24.
恶性疟原虫中的蛋白质O-岩藻糖基化确保对蚊子和脊椎动物宿主的有效感染。
Nat Commun. 2017 Sep 15;8(1):561. doi: 10.1038/s41467-017-00571-y.
4
The fibrinogen-like domain of FREP1 protein is a broad-spectrum malaria transmission-blocking vaccine antigen.FREP1蛋白的纤维蛋白原样结构域是一种广谱的疟疾传播阻断疫苗抗原。
J Biol Chem. 2017 Jul 14;292(28):11960-11969. doi: 10.1074/jbc.M116.773564. Epub 2017 May 22.
5
Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.迈向基于 PfS48/45 的疟疾传播阻断疫苗的临床开发。
Expert Rev Vaccines. 2017 Apr;16(4):329-336. doi: 10.1080/14760584.2017.1276833. Epub 2017 Jan 9.
6
The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.s48/45六半胱氨酸蛋白:疟原虫整个生命周期中相互作用的介质。
Int J Parasitol. 2017 Jun;47(7):409-423. doi: 10.1016/j.ijpara.2016.10.002. Epub 2016 Nov 27.
7
Computationally driven antibody engineering enables simultaneous humanization and thermostabilization.计算驱动的抗体工程能够实现人源化和热稳定性的同时提升。
Protein Eng Des Sel. 2016 Oct;29(10):419-426. doi: 10.1093/protein/gzw024. Epub 2016 Jun 21.
8
Dali server update.大理服务器更新。
Nucleic Acids Res. 2016 Jul 8;44(W1):W351-5. doi: 10.1093/nar/gkw357. Epub 2016 Apr 29.
9
Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics.探究疟原虫子孢子表面:基于质谱蛋白质组学鉴定表面暴露蛋白并证明环子孢子蛋白(CSP)和血小板反应蛋白相关黏附蛋白(TRAP)上的糖基化
PLoS Pathog. 2016 Apr 29;12(4):e1005606. doi: 10.1371/journal.ppat.1005606. eCollection 2016 Apr.
10
Naturally acquired immunity to sexual stage P. falciparum parasites.对恶性疟原虫有性阶段寄生虫的自然获得性免疫。
Parasitology. 2016 Feb;143(2):187-98. doi: 10.1017/S0031182015001341. Epub 2016 Jan 8.